Press Releases

HRID's Azul Instantâ„¢ Product For Erectile Dysfunction (ED) Provides All Natural Alternative For 30 Million Men In The U.S.

Stock quotes in this article:HRID 

FORT LAUDERDALE, Fla., Feb. 10, 2012 /PRNewswire/ -- In an effort to raise awareness of the prevalence of Erectile Dysfunction (ED), Nouveau Life Pharmaceuticals (soon to be changed from Hybrid Fuels, Inc., Pink Sheets: HRID) provides its customers published statistics regarding ED and the benefits of Azul Instant™ as an all-natural alternative to those suffering with the condition.  

Experts report that 30 million men in the United States have ED and one in 10 men in the world suffers from the condition. According to the Minnesota Men's Public Health Center, 50% of men with diabetes have ED, frequently within 10 years of diagnosis. The likelihood of ED increases with age: 39% at age 40, 65% over the age of 65. Smokers have a higher likelihood of erectile dysfunction. Men who smoke more than 1 pack per day have a 50% higher chance of impotency than nonsmokers the same age.

The ED prescription drug market has surpassed $5Billion in sales. Prescription drugs like Cialis, Viagra and Levitra have become famous thanks to expansive marketing campaigns. These and other ED drugs have been hailed as miracle cures for male impotence, but they have well-documented side effects including diarrhea, dizziness, flushing, headache, heartburn, stuffy nose, upset stomach and more. Other potential side effects are gravely serious, such as severe allergic reactions, chest pains, fainting, fast or irregular heartbeat, memory loss, painful or prolonged erection, vision loss and other maladies.

More men appear to be willing to admit they have problems with ED online or with surveys where identification is not required. In those studies up to 56% of the men in the survey admitted to some level of problem. 89% of men said they would take the chance with prescription drugs to see if they worked in spite of the known side effects, allergic reactions, and possible health risks.

The Company recently announced the introduction of Azul Instant™, an all-natural supplement  for ED that provides the millions of men suffering from the condition with a safe alternative to prescription drugs.  Developed by a team of experts, the Company's goal is to create the healthiest and most effective all-natural male enhancer ever formulated. Unlike pharmaceutical drugs such as Cialis, Viagra and Levitra, Azul Instant™, carries no dangerous side effects. 

TheStreet Premium Services

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,454.83 1,317.82 2,837.53 17.45
Oil *
107.26
DOWN
74.92
DOWN
2.86
DOWN
1.85
DOWN
0.14
10 Yr
1.74%
SPDR Gold
152.68
-0.60%
-0.22%
-0.07%
-0.80%
Data delayed 20 minutes

Top Stories and Tools

Articles From

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet